- Home
- /
- News
- /
- Drug Trials
- /
- November 2009
Drug Trials News for November 2009
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010.
19 November, 2009
Astex Therapeutics Limited recently announced the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to collaborate on the study of its novel small-molecule HSP90 inhibitor, AT13387, for the treatment of cancer.
06 November, 2009
This will be the first evaluation of CureVac's RNActive® vaccine technology in humans.
05 November, 2009